50.57
Schlusskurs vom Vortag:
$51.07
Offen:
$50.72
24-Stunden-Volumen:
1.02M
Relative Volume:
0.74
Marktkapitalisierung:
$11.06B
Einnahmen:
$1.98B
Nettoeinkommen (Verlust:
$83.59M
KGV:
135.21
EPS:
0.374
Netto-Cashflow:
$502.31M
1W Leistung:
+0.34%
1M Leistung:
+5.86%
6M Leistung:
+13.61%
1J Leistung:
+9.96%
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie QGEN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
QGEN
Qiagen Nv
|
50.57 | 11.06B | 1.98B | 83.59M | 502.31M | 0.374 |
![]()
TMO
Thermo Fisher Scientific Inc
|
477.28 | 182.01B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
203.99 | 148.12B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
572.09 | 46.09B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
118.05 | 34.04B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
191.54 | 33.07B | 15.50B | 1.33B | 2.16B | 7.34 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-24 | Eingeleitet | Barclays | Overweight |
2025-04-04 | Herabstufung | Redburn Atlantic | Buy → Neutral |
2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2025-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
2021-10-15 | Fortgesetzt | Cowen | Market Perform |
2021-10-14 | Eingeleitet | Redburn | Buy |
2021-07-14 | Herabstufung | Kepler | Buy → Hold |
2021-06-03 | Eingeleitet | Goldman | Neutral |
2020-10-06 | Fortgesetzt | BofA Securities | Buy |
2020-09-28 | Hochstufung | Kepler | Hold → Buy |
2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
2020-01-07 | Eingeleitet | Citigroup | Neutral |
2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
2019-11-15 | Eingeleitet | Stifel | Hold |
2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
How strong is Qiagen N.V. company’s balance sheetBeginner Investor Review Backed By Experts - jammulinksnews.com
What is the dividend policy of Qiagen N.V. stockLow Risk Forecasts For Smart Trading - jammulinksnews.com
Why Qiagen N.V. stock attracts strong analyst attentionShort Term Setup With Predictive Chart Confirmed - beatles.ru
Qiagen N.V. Announces BlackRock’s Significant Stake in Voting Rights - TipRanks
Will Qiagen N.V. Benefit From Sector TailwindsTop Performing Stock Insights Released Daily - metal.it
Key External Factors That Drive Qiagen N.V. Stock Price MovementsEntry Plan for Oversold Reversal Stocks Released - metal.it
Chart Analysts Warn of Resistance Near Qiagen N.V. PriceBuy Alerts With Low Risk Confirmation Noted - metal.it
Is Qiagen N.V. a Top Dividend Stock to Watch in 2025Scalable Portfolio Growth Suggestions Released - metal.it
COVID-19 Saliva-Based Detection Kits Market to reach US$ 1.2 Bn - openPR.com
Why is Qiagen N.V. stock attracting strong analyst attentionCapitalize on market trends before they peak - jammulinksnews.com
When is Qiagen N.V. stock expected to show significant growthUnlock superior stock analysis tools - jammulinksnews.com
What are the latest earnings results for Qiagen N.V.Take advantage of unprecedented market momentum - jammulinksnews.com
What makes Qiagen N.V. stock price move sharplyAccess powerful market insights for free - jammulinksnews.com
What are analysts’ price targets for Qiagen N.V. in the next 12 monthsStay ahead with daily expert stock picks - jammulinksnews.com
What are Qiagen N.V. company’s key revenue driversInvest confidently with professional market insights - jammulinksnews.com
Qiagen Sees Price Target Raised to EUR 50 by Berenberg Analyst - AInvest
What analysts say about Qiagen N.V. stockOutstanding trading profits - PrintWeekIndia
Qiagen Announces BlackRock’s Significant Voting Rights - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Is Qiagen N.V. a good long term investmentLightning-fast capital gains - PrintWeekIndia
What drives Qiagen N.V. stock priceFree Investment Portfolio Suggestions - PrintWeekIndia
Berenberg Bank Maintains Qiagen NV(QGEN.US) With Buy Rating, Raises Target Price to $58.72 - 富途牛牛
Qiagen (QGEN) Sees Price Target Raised by Berenberg Analyst | QGEN Stock News - GuruFocus
Qiagen N.V.'s (NYSE:QGEN) high institutional ownership speaks for itself as stock continues to impress, up 4.3% over last week - Yahoo Finance
Berenberg raises Qiagen stock price target to EUR50 on growth pillars - Investing.com Canada
Berenberg raises Qiagen stock price target to EUR50 on growth pillars By Investing.com - Investing.com South Africa
Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term - Yahoo Finance
QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels - BioSpace
BlackRock Discloses Significant Stake in Qiagen - AInvest
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - Pressetext
Qiagen Announces Voting Rights Notification Involving BlackRock - TipRanks
BlackRock’s Significant Stake in Qiagen Disclosed by AFM - TipRanks
QIAGEN launches long read sequencing panels for complex genomic analysis - StreetInsider
Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen N.V. Stock Analysis and ForecastUnmatched profit growth - jammulinksnews.com
Qiagen NV stock reaches 52-week high at 48.91 USD By Investing.com - Investing.com Canada
Qiagen NV stock reaches 52-week high at 48.91 USD - Investing.com India
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):